INSM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- FDA granted Priority Review to Insmed’s sNDA for ARIKAYCE for MAC lung disease, with a PDUFA target action date of January 28, 2027Sep 21, 2026
- Japan's Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib) for patients with non-cystic fibrosis bronchiectasisAug 24, 2026
- Insmed reported positive 12-month data from the open-label extension study of TPIP in pulmonary arterial hypertensionJul 16, 2026
- Insmed reported positive Phase 3b ENCORE topline results for ARIKAYCE in MAC lung diseaseMar 23, 2026
- Insmed reports positive results from Phase 2b study of TPIP for pulmonary hypertensionJun 10, 2025